IGFBP-3 is the major carrier protein for circulating IGF-1, and suppression has implications for endogenous IGF-1 bioavailability post-cycle
The differences between the individual values of GSH content of liver determined in this assay were small, thus, confirming the literature report that GSH content of liver did not change when an animal was pretreated with microsomal drug-metabolizing inducers such as phenobarbitone, 3-methylcholanthrene and polychlorinated biphenyl (Arcolor 1254)
Potential adverse effects related to chronic GH/IGF-1 elevation represent an important theoretical concern
Plays a crucial role in protecting cells from oxidative damage by preventing tissue lipid peroxidation (By similarity)
10.1016/j.ejphar.2021.174279 2 AgahS.AkbariA.SadeghiE.MorvaridzadehM.BasharatZ.PalmowskiA.et al (2021)
Some receptor pathways have multiple receptor subtypes or isoforms that produce the same downstream effect (Baker and Hill 2007), further increasing the likelihood that CBD could chemically interact with the pathway